NewLink Genetics (NLNK) Tops Q3 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to NewLink Genetics (NLNK) Tops Q3 EPS by 11c

NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2015 Financial Results

November 3, 2015 7:01 AM EST

AMES, Iowa, Nov. 03, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company at the forefront of developing and commercializing novel immuno-oncology product candidates, including both cellular immunotherapy and checkpoint inhibitor platforms, to improve the lives of patients with cancer, today reported consolidated financial results for the third quarter of 2015 and progress in its proprietary and partnered clinical development programs.

Our dynamic and experienced team has made significant progress in driving our broad clinical development programs, said Charles Link, M.D., Chairman and Chief Executive Officer. We look forward to reporting on our... More